Riskpilot← Back to searchSign inGet full accessForma Scientiae AB
ABActiveOrg 5592106578Åsgatan 72Beauty care and other beauty treatment activities · NACE 9622Est. 20198 employees
Revenue 2025
SEK 10M
+8% vs 2024
EBITDA margin
15.5%
-3% vs 2024
Equity ratio
38.3%
Financial strength
Net profit 2025
SEK 428K
-61% vs 2024
| Revenue | SEK 10M | +8% |
| EBITDA | SEK 1,5M | -3% |
| Net profit | SEK 428K | -61% |
| Total assets | SEK 5,5M | +3% |
| Equity | SEK 2,1M | +6% |
| Employees | 8 | — |
Legal name
Forma Scientiae AB
Org number
5592106578
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
1 juli 2019
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hudvård och skönhetsvård, estetiska och medicinska injektioner, samt import och försäljning av hudvårds- och skönhetsutrustning. Sjuk- och friskvårdstjänster, hårvård, äga och förvalta aktier samt därmed förenlig verksamhet.
Address
Åsgatan 72
Email
anna.tholen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 775 | 8 113 | 9 106 | 9 203 | 9 980 |
| Staff expenses | — | −2 613 | −4 089 | −3 788 | −4 647 |
| EBITDA | 1 334 | 2 233 | 1 262 | 1 601 | 1 549 |
| Depreciation & amort. | −66 | −87 | −119 | −217 | −177 |
| EBIT | 1 268 | 2 146 | 1 143 | 1 384 | 1 371 |
| Net financials | −4 | −4 | 0 | 20 | −638 |
| Profit before tax | 957 | 1 596 | 1 106 | 1 400 | 739 |
| Tax | −198 | −330 | −234 | −298 | −312 |
| Net profit | 759 | 1 266 | 871 | 1 103 | 428 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 896 | 4 160 | 4 746 | 5 331 | 5 480 |
| Equity | 931 | 1 697 | 2 168 | 1 971 | 2 099 |
| Long-term debt | 0 | — | — | 367 | 167 |
| Short-term debt | 1 519 | 1 472 | 1 548 | 1 960 | 2 188 |
| Total debt | 1 519 | 1 472 | 1 548 | 2 326 | 2 355 |
EBITDA margin
15.5%
This company
15.8%
Market median
+2% vs market
20212025
Equity ratio
38.3%
This company
38.2%
Market median
+0% vs market
20212025
Return on equity
20.4%
This company
18.4%
Market median
+11% vs market
20212025
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20212025
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20212025
Debt / equity
1.61×
This company
0.62×
Market median
-160% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BU Chief Auditor | Chief Auditor | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Forma Scientiae AB 
J. D. Lindhs Gjuthus ABBoard members of Forma Scientiae AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Barbro Ulrika Hagberg | Chief Auditor | 0 companies |
| Carl Håkan André Westerby | Deputy Board Member | 0 companies |
| Anna Ulrika Tholén | Board of Directors | 0 companies |